Evidence map›Paper›PMID 25195558›Full record

ArticleJournal of hepatology2015

Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL).

Daniela P Ladner, Mary Amanda Dew, Sarah Forney, Brenda W Gillespie, Robert S Brown, Robert M Merion, Chris E Freise, Paul H Hayashi, Johnny C Hong, April Ashworth and 4 more

2 registry-linked trialsOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Journal of hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01619475 completednot on this map

A2ALL: Adult-to-Adult Living Transplant Cohort Study

TypeobservationalSponsorArbor Research Collaborative for HealthRan2011 to 2014Enrolled1,871ConditionsLiver Diseases, Hepatocellular Cancer, End Stage Liver Disease, Hepatitis C
NCT05186116 narecruitingnot on this mapstarted 2022, after this paper: background citation

Living Donor Liver Transplantation (LDLT) in Non Resectable Colo-rectal Cancer Liver Metastasis. The LIVERMORE Trial (LIVing Donor livEr tRansplant Modena cOloRectal mEtastasis) [Original Title in Italian: "Trapianto di Fegato da Donatore Vivente Per Metastasi Epatiche Non Resecabili da Adenocarcinoma Del Colon"]

TypeinterventionalSponsorAzienda Ospedaliero-Universitaria di ModenaRan2022 to 2032Enrolled25ConditionsColon Adenocarcinoma, Liver Metastasis Colon CancerArmsLiving donor liver transplant, Split liver transplant, RAPID, DDLT
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Steatosis, inflammation, fibroprogression, and cirrhosis in remnant liver post-liver donation.JGH open : an open access journal of gastroenterology and hepatology · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Evaluation of Psychosocial Outcomes of Living Liver Donors in Liver Transplantation.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Health-related quality of life after anonymous nondirected living liver donation: A multicenter collaboration.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 1 country.

Daniela P LadnerNorthwestern University Transplant Outcomes Research Collaborative (NUTORC), Comprehensive Transplant Center, Northwestern University, Chicago, IL, USA. Electronic address: dladner@nmh.org.
Mary Amanda DewDepartments of Psychiatry, Psychology, Epidemiology and Biostatistics, University of Pittsburgh School of Medicine and Medical Center, Pittsburgh, PA, USA.
Sarah ForneyArbor Research Collaborative for Health, Ann Arbor, MI, USA.
Brenda W GillespieDepartment of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
Robert S BrownDepartment of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA.
Robert M MerionArbor Research Collaborative for Health, Ann Arbor, MI, USA; Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
Chris E FreiseDepartment of Surgery, University of California, San Francisco, San Francisco, CA, USA.
Paul H HayashiDepartment of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Johnny C HongDepartment of Surgery, Medical College of Wisconsin, WI, USA.
April AshworthVirginia Commonwealth University, Richmond, VA, USA.
Carl L BergDuke University Health System, Durham, NC, USA.
James R BurtonDepartment of Medicine, University of Colorado, Aurora, CO, USA.
Abraham ShakedDepartment of Surgery, University of Pennsylvania, Philadelphia, PA, USA.
Zeeshan ButtNorthwestern University Transplant Outcomes Research Collaborative (NUTORC), Comprehensive Transplant Center, Northwestern University, Chicago, IL, USA; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Arbor Research Collaborative for Health · USNorthwestern University · USColumbia University · USDuke University Health System · USMedical College of Wisconsin · USUniversity of California, San Francisco · USUniversity of Colorado Denver · USUniversity of Michigan–Ann Arbor · USUniversity of North Carolina at Chapel Hill · USUniversity of Pennsylvania · USUniversity of Pittsburgh · USVirginia Commonwealth University · US

Funding

Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Living donor liver transplant data coordinating centerU01DK062498 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MERION, ROBERT M · 2002 to 2016
$15.3M
Living Donor Liver Transplant - Predictive Models for Long-Term Health OutcomesU01DK062467 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ABECASSIS, MICHAEL M · 2002 to 2014
$4.7M
Living Donor Liver Transplant :Short & Long-Term Impact on Donors and RecipientsU01DK062444 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FREISE, CHRIS · 2002 to 2014
$3.7M
Adult to Adult Living Donor Liver Transplantation Cohort StudyU01DK062483 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI EMOND, JEAN C · 2002 to 2014
$3.5M
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)U01DK062536 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BURTON, JAMES · 2002 to 2013
$3.4M
Adult to Adult Living Donor Liver Transplantation Cohort StudyU01DK062494 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI OLTHOFF, KIM MARIE · 2002 to 2014
$3.3M
Adult to Adult Living Donor Liver TransplantationU01DK062531 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI COTTERELL, ADRIAN · 2002 to 2014
$2.7M
Living Donor Liver Transplantation Cohort StudyU01DK062484 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BERG, CARL L. · 2002 to 2010
$1.8M
ADLDT: An Opportunity to Expand the National Donor PoolU01DK062496 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HONG, JOHNNY C · 2002 to 2010
$1.8M
Right Lobe Living Donor Liver Transplantation in AdultsU01DK062505 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAYASHI, PAUL HIDEYO · 2002 to 2010
$1.2M
NCATS NIH HHS UL1 TR001082NIDDK NIH HHS U01 DK062444NIDDK NIH HHS U01 DK062467NIDDK NIH HHS U01 DK062483NIDDK NIH HHS U01 DK062484NIDDK NIH HHS U01 DK062494NIDDK NIH HHS U01 DK062496NIDDK NIH HHS U01 DK062498NIDDK NIH HHS U01 DK062505NIDDK NIH HHS U01 DK062531NIDDK NIH HHS U01 DK062536NIDDK NIH HHS U01-DK62444NIDDK NIH HHS U01-DK62467NIDDK NIH HHS U01-DK62483NIDDK NIH HHS U01-DK62484NIDDK NIH HHS U01-DK62494NIDDK NIH HHS U01-DK62496NIDDK NIH HHS U01-DK62498NIDDK NIH HHS U01-DK62505NIDDK NIH HHS U01-DK62531NIDDK NIH HHS U01-DK62536
6 · The paper itself

Abstract

BACKGROUND &

aimsThere are few long-term studies of the health-related quality of life (HRQOL) in living liver donors. This study aimed to characterize donor HRQOL in the Adult to Adult Living Donor Liver Transplantation Study (A2ALL) up to 11 years post-donation.

methodsBetween 2004 and 2013, HRQOL was assessed at evaluation, at 3 months, and yearly post-donation in prevalent liver donors using the short-form survey (SF-36), which provides a physical (PCS) and a mental component summary (MCS).

resultsOf the 458 donors enrolled in A2ALL, 374 (82%) had SF-36 data. Mean age at evaluation was 38 (range 18-63), 47% were male, 93% white, and 43% had a bachelor's degree or higher. MCS and PCS means were above the US population at all time points. However, at every time point there were some donors who reported poor scores (>1/2 standard deviation below the age and sex adjusted mean) (PCS: 5.3-26.8%, MCS: 10.0-25.0%). Predictors of poor PCS and MCS scores included recipient's death within the two years prior to the survey and education less than a bachelor's degree; poor PCS scores were also predicted by time since donation, Hispanic ethnicity, and at the 3-month post-donation time point.

conclusionsIn summary, most living donors maintain above average HRQOL up to 11 years prospectively, supporting the notion that living donation does not negatively affect HRQOL. However, targeted support for donors at risk for poor HRQOL may improve overall HRQOL outcomes for living liver donors.

Indexed as

ForecastingQuality of LifeTissue and Organ ProcurementAdolescentAdultFemaleFollow-Up StudiesHumansLiver TransplantationLiving DonorsMaleMiddle AgedRetrospective StudiesSurveys and QuestionnairesTime FactorsYoung AdultAdult to adult living donor liver transplantation cohort study (A2ALL)Living donor liver transplantationLiving liver donorsPatient reported outcomesQuality of life

Identifiers

PMID25195558
PMCPMC4300258
OpenAlexW2046698624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.